» Articles » PMID: 25073664

Failure Patterns After Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma

Overview
Specialties Oncology
Radiology
Date 2014 Jul 31
PMID 25073664
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We previously reported our technique for delivering intensity modulated radiation therapy (IMRT) to the entire pleura while attempting to spare the lung in patients with malignant pleural mesothelioma (MPM). Herein, we report a detailed pattern-of-failure analysis in patients with MPM who were unresectable or underwent pleurectomy/decortication (P/D), uniformly treated with hemithoracic pleural IMRT.

Methods And Materials: Sixty-seven patients with MPM were treated with definitive or adjuvant hemithoracic pleural IMRT between November 2004 and May 2013. Pretreatment imaging, treatment plans, and posttreatment imaging were retrospectively reviewed to determine failure location(s). Failures were categorized as in-field (within the 90% isodose line), marginal (<90% and ≥50% isodose lines), out-of-field (outside the 50% isodose line), or distant.

Results: The median follow-up was 24 months from diagnosis and the median time to in-field local failure from the end of RT was 10 months. Forty-three in-field local failures (64%) were found with a 1- and 2-year actuarial failure rate of 56% and 74%, respectively. For patients who underwent P/D versus those who received a partial pleurectomy or were deemed unresectable, the median time to in-field local failure was 14 months versus 6 months, respectively, with 1- and 2-year actuarial in-field local failure rates of 43% and 60% versus 66% and 83%, respectively (P=.03). There were 13 marginal failures (19%). Five of the marginal failures (38%) were located within the costomediastinal recess. Marginal failures decreased with increasing institutional experience (P=.04). Twenty-five patients (37%) had out-of-field failures. Distant failures occurred in 32 patients (48%).

Conclusions: After hemithoracic pleural IMRT, local failure remains the dominant form of failure pattern. Patients treated with adjuvant hemithoracic pleural IMRT after P/D experience a significantly longer time to local and distant failure than patients treated with definitive pleural IMRT. Increasing experience and improvement in target delineation minimize the incidence of avoidable marginal failures.

Citing Articles

Impact of Neoadjuvant and Adjuvant Pleural Intensity-Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma.

Mosleh B, Schwarz S, Cho A, Sinn K, Steindl A, Zochbauer-Muller S Thorac Cancer. 2025; 16(5):e70024.

PMID: 40066644 PMC: 11894436. DOI: 10.1111/1759-7714.70024.


Survey of malignant pleural mesothelioma treatment in Japan: Patterns of practice and clinical outcomes in tomotherapy facilities.

Nakanishi-Imai M, Murai T, Onishi M, Mouri A, Komiyama T, Omura M J Radiat Res. 2022; 63(2):281-289.

PMID: 35138408 PMC: 8944311. DOI: 10.1093/jrr/rrab127.


GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma.

Luna J, Bobo A, Cabrera-Rodriguez J, Pagola M, Martin-Martin M, Ruiz M World J Clin Oncol. 2021; 12(8):581-608.

PMID: 34513595 PMC: 8394157. DOI: 10.5306/wjco.v12.i8.581.


Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy.

Halpenny D, Raj M, Rimner A, Zheng J, Capanu M, Ginsberg M Eur Radiol. 2019; 29(7):3696-3704.

PMID: 30689034 PMC: 7506505. DOI: 10.1007/s00330-018-5937-6.


Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.

Thompson M, Dumane V, Lazarev S, Zia Y, Rosenzweig K Pract Radiat Oncol. 2019; 9(3):e331-e337.

PMID: 30654090 PMC: 6500743. DOI: 10.1016/j.prro.2018.12.008.


References
1.
Gomez D, Hong D, Allen P, Welsh J, Mehran R, Tsao A . Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol. 2012; 8(2):238-45. PMC: 5610569. DOI: 10.1097/JTO.0b013e31827740f0. View

2.
Zauderer M, Krug L . Pleurectomy/decortication, chemotherapy, and intensity modulated radiation therapy for malignant pleural mesothelioma: rationale for multimodality therapy incorporating lung-sparing surgery. Ann Cardiothorac Surg. 2013; 1(4):487-90. PMC: 3741800. DOI: 10.3978/j.issn.2225-319X.2012.10.08. View

3.
Damast S, Wolden S, Lee N . Marginal recurrences after selective targeting with intensity-modulated radiotherapy for oral tongue cancer. Head Neck. 2011; 34(6):900-6. DOI: 10.1002/hed.21677. View

4.
HOLSTI L, Pyrhonen S, Kajanti M, Mantyla M, Mattson K, Maasilta P . Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment. Acta Oncol. 1997; 36(4):397-405. DOI: 10.3109/02841869709001287. View

5.
Treasure T, Lang-Lazdunski L, Waller D, Bliss J, Tan C, Entwisle J . Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011; 12(8):763-72. PMC: 3148430. DOI: 10.1016/S1470-2045(11)70149-8. View